← Back to Search

Regional Anesthesia

ESP Block Anesthesia for Microtia Surgery

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 2-17
Pediatric patients undergoing rib cartilage resection surgeries
Must not have
Patients who are clinically unstable or require urgent/emergent intervention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of study (typically 4-5 days)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to numb the chest and stomach during surgery. They want to see if it decreases pain and the amount of pain medication needed afterwards.

Who is the study for?
This trial is for children and teenagers aged 2-17 who are having surgery to correct ear deformities using rib cartilage. They must be able to agree to the study themselves if they're over 7, or have their parents' consent.
What is being tested?
The trial is testing a new pain-blocking technique called Erector Spinae Plane Block in kids and teens undergoing ear surgeries with rib cartilage grafts. It aims to see if this method reduces pain and the need for strong painkillers after surgery.
What are the potential side effects?
While specific side effects aren't listed, regional anesthesia techniques like ESP blocks may cause discomfort at the injection site, itching, or numbness beyond the targeted area.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 2 and 17 years old.
Select...
I am a child scheduled for rib cartilage surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need immediate medical attention for my condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of study (typically 4-5 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of study (typically 4-5 days) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluating Pain Scores Using 0-10 Numeric Pain Scale (0=No Pain, 10=Worst Pain)
Evaluating Pain Scores Using Faces, Legs, Activity, Cry, and Consolability (FLACC) Scale
Evaluating Pain Scores Using Wong-Baker FACES Pain Rating Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment ArmExperimental Treatment1 Intervention
ESP Block
Group II: Control ArmActive Control1 Intervention
Standard of Care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Erector Spinae Plane Block
2020
Completed Phase 2
~1060

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,469 Previous Clinical Trials
17,501,697 Total Patients Enrolled

Media Library

Erector Spinae Plane Block (Regional Anesthesia) Clinical Trial Eligibility Overview. Trial Name: NCT03729427 — N/A
Microtia Research Study Groups: Treatment Arm, Control Arm
Microtia Clinical Trial 2023: Erector Spinae Plane Block Highlights & Side Effects. Trial Name: NCT03729427 — N/A
Erector Spinae Plane Block (Regional Anesthesia) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03729427 — N/A
~0 spots leftby Dec 2024